GELS: Gelteq Limited Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 15.67
Enterprise Value ($M) n/a
Book Value ($M) 15.11
Book Value / Share 1.60
Price / Book n/a
NCAV ($M) -5.34
NCAV / Share -0.57
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.19
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 0.08
Current Ratio 0.08

Balance Sheet (mrq) ($M)
Current Assets 0.30
Assets 20.76
Liabilities 5.65
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.14
Operating Income -2.61
Net Income -3.55

Cash Flow Statement (mra) ($M)
Cash From Operations -1.07
Cash from Investing -0.15
Cash from Financing 0.84

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 2,839 33,208 8.55
2024-11-21 3,033 27,811 10.91
2024-11-20 1,453 7,793 18.64
2024-11-19 1,666 10,083 16.52

(click for more detail)

Similar Companies
FTLF – FitLife Brands, Inc. GALT – Galectin Therapeutics Inc.
GDTC – CytoMed Therapeutics Limited GLMD – Galmed Pharmaceuticals Ltd.
GLSI – Greenwich LifeSciences, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.